Nazaré Launches AI Academy to Help Organizations Drive Confident and Responsible AI Adoption

Nazaré’s AI Academy helps organizations build confidence, skills, and responsible AI adoption through practical training and hands-on learning.

Nazaré, part of Inizio Engage, has launched its AI Academy in collaboration with employee experience consultancy Forty1 to help organizations move beyond AI experimentation and build the skills, confidence, and behaviors needed for successful adoption. Designed using behavioral science insights and workplace learning expertise, the program addresses the growing challenge of turning AI investments into measurable business impact by providing employees with practical training, hands-on application, and leadership enablement. The AI Academy offers three learning pathways—Learn, Explore, and Speak—focused on building foundational AI skills, developing real-world use cases, and preparing leaders to support responsible AI adoption. The program also emphasizes compliance, risk awareness, and human oversight to help organizations integrate AI effectively across teams and industries.

“We’re seeing huge investment in AI, but far less confidence when it comes to actually using it day to day,” said Shawn Jordan, Director of AI and Augmented Learning Strategy at Nazaré. “We built the AI Academy to change that. It’s about giving people the confidence, the guardrails and the hands-on experience to put AI to work in a way that’s practical, responsible and genuinely valuable.”

Moon Rabbit Expands Client Portfolio and Leadership Team Amid Continued Industry Recognition
Independent advertising and media agency Moon Rabbit is expanding its client roster, leadership team, and industry presence as it continues its growth in 2026. The agency has secured new partnerships with brands including LEO Pharma, Scholar Rock, Mayne Pharma, BVI, and American Express, while strengthening its integrated creative and media capabilities to help organizations better connect with their audiences and drive measurable results. Moon Rabbit also welcomed new executive leadership and earned recognition as Agency of the Year at the 37th annual Manny Awards, along with additional industry honors recognizing its creative work, media strategy, and business impact. The agency’s recent achievements reflect its continued focus on combining audience insights, creative strategy, and media expertise to support impactful brand campaigns across healthcare and other industries. “Our growth has come from ambitious clients who want to challenge the status quo and from teams that share this ambition and bring real curiosity and care to the work,” said Moon Rabbit Managing Director James Tinker. “We’re proud to be building an agency where intimacy with audiences leads to better thinking, stronger creativity, and measurable impact. It’s incredibly rewarding to see that approach recognized at the highest level.”

CMI Media Group Launches Ad Astra to Transform Life Sciences Advertising Through Connected Data and Technology
CMI Media Group has launched Ad Astra, a new advertising technology division designed to help life sciences organizations overcome fragmented systems, disconnected data, and challenges in measuring marketing impact. Built specifically for advertisers, publishers, and agencies, Ad Astra combines precision data solutions, advanced advertising technology, and omnichannel orchestration capabilities to help organizations create more connected customer experiences and drive measurable outcomes. The platform offers flexible self-service and managed service options, enabling companies to better integrate data, optimize engagement strategies, and improve marketing performance. Drawing on CMI Media Group’s experience supporting complex life sciences campaigns, Ad Astra aims to provide a more unified approach to data-driven healthcare advertising and help organizations turn insights into actionable strategies.

“With Ad Astra, we believe the future of marketing performance depends on integration, intelligence, and flexibility,” said Oleg Korenfeld, Chief Technology Officer at CMI Media Group. “Companies no longer need more disconnected tools—they need connected, modular capabilities that work together to transform data into action and marketing into measurable business growth.

Real Chemistry Unifies Media and Omnichannel Capabilities Through New Technology-Led Practice
Real Chemistry has launched Real Chemistry Media, a unified healthcarefocused media and omnichannel practice that combines its legacy capabilities with recent acquisitions Greater Than One and Spring & Bond. Bringing together approximately 450 media experts and more than 150 data and analytics professionals, the new practice is designed to help healthcare marketers deliver more connected, personalized, and data-driven customer engagement. Real Chemistry Media will leverage proprietary data, AIpowered technology, and advanced analytics through its omnichannel orchestration platform, which supports real-time personalization, next-bestaction strategies, and measurement. The company is also collaborating with AWS to enhance the platform’s scalability and technology capabilities as it continues to build a future-focused approach to healthcare marketing and communications.

“With Real Chemistry Media, we’re bringing together end-to-end media and omnichannel solutions with proprietary data, advanced AI and automation technology, and insights-led strategy,” said Kevin Johnson, Group President and Managing Partner of Real Chemistry. “The integration is designed to meet healthcare brands’ growing demand for more connected, personalized, data-driven customer engagement at scale.”

Klick Health Acquires Oxford PharmaGenesis to Expand Scientificto-Commercial Capabilities for Life Sciences Clients

Klick Health has acquired Oxford PharmaGenesis, a leading HealthScience communications consultancy, bringing together complementary expertise across medical affairs, market access, real-world evidence (RWE), health economics and outcomes research (HEOR), commercial strategy, creative, digital, and analytics.

The acquisition strengthens Klick Health’s ability to support life sciences companies throughout the entire commercialization journey by combining deep scientific expertise with advanced technology and commercial capabilities. The partnership expands Klick’s global presence, therapeutic expertise, and team of scientific professionals while providing clients with enhanced support in developing evidence-based strategies, engaging stakeholders, and bringing healthcare innovations to market. The combined organization aims to help life sciences companies navigate evolving industry needs through integrated scientific and commercial solutions.

“The partnership expands Klick’s global presence, therapeutic expertise, and team of scientific professionals while providing clients with enhanced support in developing evidence-based strategies, engaging stakeholders, and bringing healthcare innovations to market.”

“We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific- tocommercial offering that unlocks the true potential of their innovations,” said Leerom Segal, Klick’s Co-Founder and Chairman. “From the moment we met, we were struck by all the commonalities we share and how rare it is for two organizations’ independence, work ethic, ethos, and histories to mirror each other quite like ours. We think it’s an important distinction that will set clients and team members up for success.”